Cytocure LLC is categorized under Biological Products Manufacturers in Beverly, MA and active since 1999.
Cytocure LLC was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact James Kurnick at the company’s single location by writing to 100 Cummings Center # 430c, Beverly, Massachusetts MA 01915 or by phoning (978) 232-1243. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cytocure LLC |
| Contact Person: | James Kurnick |
| Address: | 100 Cummings Center # 430c, Beverly, Massachusetts 01915 |
| Phone Number: | (978) 232-1243 |
| Website Address: | cytocure.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Cytocure LLC was started in 1999 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact James Kurnick for inquiries that concern Cytocure LLC by calling the company number (978) 232-1243, as your correspondence is most welcome. Additionally, the physical location of the single location of Cytocure LLC can be found at the coordinates 42.558249,-70.887198 as well as the street address 100 Cummings Center # 430c in Beverly, Massachusetts 01915.
For its online presence, you may visit Cytocure LLC’s website at cytocure.com and engage with its social media outlets through on Twitter and on Facebook.